Topics

Valhalla Private Capital Inc. and Health City Partner to Deliver Learning Opportunity for Innovators and Investors

10:00 EDT 13 Sep 2019 | Businesswire

Unique investor mentorship opportunity provides learning and tools for health and life sciences companies

Valhalla Private Capital Inc. (“Valhalla”) and Health City are pleased to announce that they have entered a formal collaboration to provide opportunities for health and life sciences companies.

Recognizing that generating investment capital is a crucial lifeline for a company to thrive, Health City and Valhalla have partnered to deliver investor mentorship to health and life sciences companies with health sector-specific experts. The closed-door sessions will be followed by a public forum where the mentors will share their observations and investment expertise. The goal of the public forum is to educate entrepreneurs and investors looking to thrive in the new health economy.

“Providing innovators with opportunities like this gives them the tools they need for investment attraction, allowing for scale and spread of their solutions to global markets,” stated Antonio Bruni, Health City Manager of Business Development. “Health City’s partnership with Valhalla is another example of how we’re leveraging our region’s networks to support our innovators.”

“Our goal is to bring individual investors from major life sciences hubs across North America to meet with and advise Alberta companies to help them reach new heights and expand internationally,” added Ryan Heit, Co-Founder, Valhalla Capital Inc. “Our investors are there to help each company grow in some unique capacity, whether it's looking for potential investment, introducing them to other investors or expertise in their network or simply providing feedback to their pitch or strategy."

Investment mentorship will be delivered in personalized, 90-minute sessions to each participating company beginning October 24, with a public event held on October 25th at the Edmonton Convention Centre. This event will be the first of many opportunities in this collaboration to enhance the investor-readiness of our region’s life sciences and health sector companies. More details about this opportunity are coming soon.

About Valhalla Private Capital Inc.

Valhalla Private Capital is a full-service corporate finance firm that started as a single city angel investor group, Valhalla Angels, in 2003. The Valhalla mission is all about inviting all people who care about their local business climate into the private capital ecosystem, giving them the tools and opportunities to participate successfully in both investing or building some great companies. At Valhalla, we believe a more sophisticated approach exists through our full suite of capital options coupled with education, training and advisory services operating under a five-pillar business model, where Valhalla Angels represents a key business pillar, angel investing. For more information, visit www.valhallaangels.com

About Health City

Health City is a non-profit, municipal economic development initiative created to connect, promote, catalyze and accelerate innovation in the health sector in Edmonton and surrounding region. Health City works with our community to create a vibrant health industry with health and social outcomes for our citizens. Our focus is on transforming innovations from our health ecosystem into solutions that have commercial application and global relevance; adopting them for impact in Edmonton and scaling them for export to global markets. For more information, visit www.edmontonhealthcity.ca

Media Contacts
Heather Pontikes
Marketing & Communications Director
Valhalla Private Capital Inc.
E: hpontikes@valhallaprivatecap.com

Karen Gilchrist
Director, Communications
Health City
P: 780.720.5446
E: kgilchrist@edmontonhealthcity.ca

NEXT ARTICLE

More From BioPortfolio on "Valhalla Private Capital Inc. and Health City Partner to Deliver Learning Opportunity for Innovators and Investors"

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...